Literature DB >> 15110313

Brachytherapy in the treatment of Stage IV carcinoma of the base of tongue.

Elmer R Cano1, Jonas T Johnson, Ricardo Carrau, Sanjiv Agarwala, John Flickinger, Mubina Quader.   

Abstract

PURPOSE: Survival in patients with Stage IV carcinoma of the base of tongue (BOT) treated by surgery and radiotherapy remains poor. External beam radiotherapy (EBRT) and brachytherapy (BT) have been used as an alternative treatment. METHODS AND MATERIALS: Eighteen patients with Stage IV carcinoma of the BOT were treated by EBRT and BT.
RESULTS: Local control is 89%. The 5-year overall (OS) and disease specific survival (DSS) rates are 52% and 67%. No neck node positive patient implanted in the neck developed cervical metastases. Two patients (11%) developed complications.
CONCLUSIONS: Local regional control, survival, and complications in patients with Stage IV carcinoma of the BOT treated by EBRT and BT have been satisfactory. The use of brachytherapy for nodal metastases has eliminated the need for neck dissection. We recommend this approach in the treatment of Stage IV carcinoma of the BOT.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15110313     DOI: 10.1016/j.brachy.2004.02.001

Source DB:  PubMed          Journal:  Brachytherapy        ISSN: 1538-4721            Impact factor:   2.362


  2 in total

Review 1.  Modern head and neck brachytherapy: from radium towards intensity modulated interventional brachytherapy.

Authors:  György Kovács
Journal:  J Contemp Brachytherapy       Date:  2014-12-31

2.  Head and neck (192)Ir HDR-brachytherapy dosimetry using a grid-based Boltzmann solver.

Authors:  Frank-André Siebert; Sabine Wolf; George Kóvacs
Journal:  J Contemp Brachytherapy       Date:  2013-12-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.